OBJECTIVE: The authors tested a strategy for screening Internet sites to identify those that provide scientifically accurate information regarding complementary/alternative medicine treatments commonly used by cancer patients. METHOD: Separate Internet searches were conducted for three complementary/alternative medicine treatments: floressence, amalaki, and selenium. Sites (N=194) were assessed according to four criteria: availability of online purchasing, inclusion of patient testimonials, description of the treatment as a "cancer cure," and description of the treatment as "having no side effects." The presence of any of these criteria was considered a "red flag" denoting questionable scientific accuracy of the site. Sites were categorized based on the number of red flags. MEDLINE searches were performed and peer-reviewed literature used to determine the scientific accuracy of sites. RESULTS: Over 90% of the sites for floressence and amalaki had at least one red flag. In these searches, sites with no red flags provided some scientifically accurate information, while sites with red flags provided a large amount of vague and inaccurate information. Less than one-quarter of sites for selenium had at least one red flag, and sites in this search generally provided scientifically accurate information, regardless of the number of red flags. CONCLUSIONS: There is a staggering amount of medical misinformation on the Internet. For cancer treatments that have not been rigorously studied, the red flag criteria offer a rapid way of screening Internet sites for likely scientific accuracy. It may be advisable for patients to avoid sites with one or more red flags.
OBJECTIVE: The authors tested a strategy for screening Internet sites to identify those that provide scientifically accurate information regarding complementary/alternative medicine treatments commonly used by cancerpatients. METHOD: Separate Internet searches were conducted for three complementary/alternative medicine treatments: floressence, amalaki, and selenium. Sites (N=194) were assessed according to four criteria: availability of online purchasing, inclusion of patient testimonials, description of the treatment as a "cancer cure," and description of the treatment as "having no side effects." The presence of any of these criteria was considered a "red flag" denoting questionable scientific accuracy of the site. Sites were categorized based on the number of red flags. MEDLINE searches were performed and peer-reviewed literature used to determine the scientific accuracy of sites. RESULTS: Over 90% of the sites for floressence and amalaki had at least one red flag. In these searches, sites with no red flags provided some scientifically accurate information, while sites with red flags provided a large amount of vague and inaccurate information. Less than one-quarter of sites for selenium had at least one red flag, and sites in this search generally provided scientifically accurate information, regardless of the number of red flags. CONCLUSIONS: There is a staggering amount of medical misinformation on the Internet. For cancer treatments that have not been rigorously studied, the red flag criteria offer a rapid way of screening Internet sites for likely scientific accuracy. It may be advisable for patients to avoid sites with one or more red flags.
Authors: Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam Journal: J Cancer Surviv Date: 2010-10-06 Impact factor: 4.442
Authors: Magda Paul; B Davey; B Senf; C Stoll; K Münstedt; R Mücke; Oliver Micke; F J Prott; J Buentzel; Jutta Hübner Journal: J Cancer Res Clin Oncol Date: 2013-07-06 Impact factor: 4.553
Authors: Deb Feldman-Stewart; Sarah Brennenstuhl; Kathryn McIssac; Joan Austoker; Agathe Charvet; Paul Hewitson; Karen R Sepucha; Tim Whelan Journal: Health Expect Date: 2007-03 Impact factor: 3.377
Authors: Jutta Huebner; Karsten Muenstedt; Franz J Prott; Christoph Stoll; Oliver Micke; Jens Buentzel; Ralph Muecke; Bianca Senf Journal: Breast Care (Basel) Date: 2014-02 Impact factor: 2.860
Authors: Thomas Elsner; Ralph Muecke; Oliver Micke; Franz J Prott; Karsten Muenstedt; Anita Waldmann; Jan Geissler; Jutta Huebner Journal: J Cancer Res Clin Oncol Date: 2013-03-16 Impact factor: 4.553